“Emerging evidence of SGLT2-inhibitor therapy in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes”, pntmj, vol. 5, no. 1, Oct. 2026, Accessed: Nov. 02, 2026. Available: https://bsgdtphcm.vn/ojs/index.php/pnt/article/view/260